CQ-16 is an orally active small molecule drug conjugate (SMDC) targeting prostate-specific membrane antigen (PSMA). CQ-16 exhibits highly selective antiproliferative activity between PSMA-positive and PSMA-negative prostate cells. In addition, CQ-16 also has PARP inhibitory activity (IC50=1 nM). (Pink: PSMA Ligand (HY-139840), Black: Linker (HY-W037980), Blue: PARP Inhibitor (HY-10162))[1]
Molekulargewicht:
850.85
CAS Nummer:
[3024354-59-1]
Formel:
C40H47FN8O12
Target-Kategorie:
PARP,PSMA
Anwendungsbeschreibung:
Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten